Cartesian Therapeutics's total assets for Q4 2024 were $435.02M, a decrease of -4.46% from the previous quarter. RNAC total liabilities were $441.82M for the fiscal quarter, a -2.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.